| Dr Manikandan Sugumaran, MD | |
|
4530 E Shea Blvd Ste 180, Phoenix, AZ 85028-6042 | |
| (602) 264-4834 | |
| (602) 254-5178 |
| Full Name | Dr Manikandan Sugumaran |
|---|---|
| Gender | Male |
| Speciality | Otolaryngology |
| Experience | 16 Years |
| Location | 4530 E Shea Blvd Ste 180, Phoenix, Arizona |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1932356367 | NPI | - | NPPES |
| 709451 | Medicaid | AZ |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Y00000X | Otolaryngology | 46359 (Arizona) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Banner - University Medical Center Phoenix | Phoenix, AZ | Hospital |
| St. Joseph's Hospital And Medical Center | Phoenix, AZ | Hospital |
| Scottsdale Thompson Peak Medical Center | Scottsdale, AZ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Bhsm Rehabilitation Llc | 2062773138 | 1258 |
| Arizona Otolaryngology Consultants, Pc | 5294621868 | 16 |
News Archive
Lantheus Medical Imaging, Inc., a worldwide leader in diagnostic imaging, today announced data from a Phase 2 clinical trial that demonstrated Positron Emission Tomography myocardial perfusion imaging with flurpiridaz F 18 provided superior image quality, diagnostic certainty and diagnostic performance for detecting coronary artery disease (CAD) compared to single photon emission computed tomography myocardial perfusion imaging, the current standard for the non-invasive detection of CAD.
The primary aim of any vaccine is to stimulate immune functions and confer long-lasting protection. A paper recently uploaded to the preprint server bioRxiv by Tong et al. (17th Feb 2021) describes a novel vaccine utilizing PIKA adjuvant and recombinant spike proteins against COVID-19 disease that promises the generation of potent neutralization antibodies, which potentially support immune responses for years.
Mountain Acquisition Corp. and Mountain Merger Sub Corp., both affiliates of Vestar Capital Partners V, L.P. formed for the purpose of acquiring Health Grades, Inc., today announced that, in accordance with the previously announced Agreement and Plan of Merger, dated as of July 27, 2010, among Mountain Acquisition Corp., Mountain Merger Sub Corp., Mountain Acquisition Holdings, LLC and HealthGrades, they have commenced a tender offer to acquire all of the outstanding shares of HealthGrades' common stock for $8.20 per share in cash.
A study published today in Age and Ageing, the scientific journal of the British Geriatrics Society, reports that the number of older people diagnosed with four or more diseases will double between 2015 and 2035. A third of these people will be diagnosed with dementia, depression or a cognitive impairment.
Imagine being diagnosed with one of the most rare and aggressive forms of breast cancer, given a five percent chance to live and told having children will never be an option. Southern California local Kommah McDowell was told just that— and then she went to City of Hope.
› Verified 7 days ago
| Entity Name | Arizona Otolaryngology Consultants, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1679538441 PECOS PAC ID: 5294621868 Enrollment ID: O20040223000589 |
News Archive
Lantheus Medical Imaging, Inc., a worldwide leader in diagnostic imaging, today announced data from a Phase 2 clinical trial that demonstrated Positron Emission Tomography myocardial perfusion imaging with flurpiridaz F 18 provided superior image quality, diagnostic certainty and diagnostic performance for detecting coronary artery disease (CAD) compared to single photon emission computed tomography myocardial perfusion imaging, the current standard for the non-invasive detection of CAD.
The primary aim of any vaccine is to stimulate immune functions and confer long-lasting protection. A paper recently uploaded to the preprint server bioRxiv by Tong et al. (17th Feb 2021) describes a novel vaccine utilizing PIKA adjuvant and recombinant spike proteins against COVID-19 disease that promises the generation of potent neutralization antibodies, which potentially support immune responses for years.
Mountain Acquisition Corp. and Mountain Merger Sub Corp., both affiliates of Vestar Capital Partners V, L.P. formed for the purpose of acquiring Health Grades, Inc., today announced that, in accordance with the previously announced Agreement and Plan of Merger, dated as of July 27, 2010, among Mountain Acquisition Corp., Mountain Merger Sub Corp., Mountain Acquisition Holdings, LLC and HealthGrades, they have commenced a tender offer to acquire all of the outstanding shares of HealthGrades' common stock for $8.20 per share in cash.
A study published today in Age and Ageing, the scientific journal of the British Geriatrics Society, reports that the number of older people diagnosed with four or more diseases will double between 2015 and 2035. A third of these people will be diagnosed with dementia, depression or a cognitive impairment.
Imagine being diagnosed with one of the most rare and aggressive forms of breast cancer, given a five percent chance to live and told having children will never be an option. Southern California local Kommah McDowell was told just that— and then she went to City of Hope.
› Verified 7 days ago
| Entity Name | Banner - University Physician Specialists Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1437529245 PECOS PAC ID: 5991008054 Enrollment ID: O20160122001476 |
News Archive
Lantheus Medical Imaging, Inc., a worldwide leader in diagnostic imaging, today announced data from a Phase 2 clinical trial that demonstrated Positron Emission Tomography myocardial perfusion imaging with flurpiridaz F 18 provided superior image quality, diagnostic certainty and diagnostic performance for detecting coronary artery disease (CAD) compared to single photon emission computed tomography myocardial perfusion imaging, the current standard for the non-invasive detection of CAD.
The primary aim of any vaccine is to stimulate immune functions and confer long-lasting protection. A paper recently uploaded to the preprint server bioRxiv by Tong et al. (17th Feb 2021) describes a novel vaccine utilizing PIKA adjuvant and recombinant spike proteins against COVID-19 disease that promises the generation of potent neutralization antibodies, which potentially support immune responses for years.
Mountain Acquisition Corp. and Mountain Merger Sub Corp., both affiliates of Vestar Capital Partners V, L.P. formed for the purpose of acquiring Health Grades, Inc., today announced that, in accordance with the previously announced Agreement and Plan of Merger, dated as of July 27, 2010, among Mountain Acquisition Corp., Mountain Merger Sub Corp., Mountain Acquisition Holdings, LLC and HealthGrades, they have commenced a tender offer to acquire all of the outstanding shares of HealthGrades' common stock for $8.20 per share in cash.
A study published today in Age and Ageing, the scientific journal of the British Geriatrics Society, reports that the number of older people diagnosed with four or more diseases will double between 2015 and 2035. A third of these people will be diagnosed with dementia, depression or a cognitive impairment.
Imagine being diagnosed with one of the most rare and aggressive forms of breast cancer, given a five percent chance to live and told having children will never be an option. Southern California local Kommah McDowell was told just that— and then she went to City of Hope.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Manikandan Sugumaran, MD 4530 E Shea Blvd Ste 180, Phoenix, AZ 85028-6042 Ph: (602) 264-4834 | Dr Manikandan Sugumaran, MD 4530 E Shea Blvd Ste 180, Phoenix, AZ 85028-6042 Ph: (602) 264-4834 |
News Archive
Lantheus Medical Imaging, Inc., a worldwide leader in diagnostic imaging, today announced data from a Phase 2 clinical trial that demonstrated Positron Emission Tomography myocardial perfusion imaging with flurpiridaz F 18 provided superior image quality, diagnostic certainty and diagnostic performance for detecting coronary artery disease (CAD) compared to single photon emission computed tomography myocardial perfusion imaging, the current standard for the non-invasive detection of CAD.
The primary aim of any vaccine is to stimulate immune functions and confer long-lasting protection. A paper recently uploaded to the preprint server bioRxiv by Tong et al. (17th Feb 2021) describes a novel vaccine utilizing PIKA adjuvant and recombinant spike proteins against COVID-19 disease that promises the generation of potent neutralization antibodies, which potentially support immune responses for years.
Mountain Acquisition Corp. and Mountain Merger Sub Corp., both affiliates of Vestar Capital Partners V, L.P. formed for the purpose of acquiring Health Grades, Inc., today announced that, in accordance with the previously announced Agreement and Plan of Merger, dated as of July 27, 2010, among Mountain Acquisition Corp., Mountain Merger Sub Corp., Mountain Acquisition Holdings, LLC and HealthGrades, they have commenced a tender offer to acquire all of the outstanding shares of HealthGrades' common stock for $8.20 per share in cash.
A study published today in Age and Ageing, the scientific journal of the British Geriatrics Society, reports that the number of older people diagnosed with four or more diseases will double between 2015 and 2035. A third of these people will be diagnosed with dementia, depression or a cognitive impairment.
Imagine being diagnosed with one of the most rare and aggressive forms of breast cancer, given a five percent chance to live and told having children will never be an option. Southern California local Kommah McDowell was told just that— and then she went to City of Hope.
› Verified 7 days ago
Dr. Shawn Michael Stevens, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 2910 N 3rd Ave # 330, Phoenix, AZ 85013 Phone: 602-406-8811 Fax: 602-406-8810 | |
Charles R Orozco, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 4250 E Camelback, Suite K-250, Phoenix, AZ 85018 Phone: 602-253-9026 Fax: 602-252-6391 | |
John David Macias, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1515 N 9th St, Suite B, Phoenix, AZ 85006 Phone: 602-257-4228 Fax: 602-252-6416 | |
Dr. Michael L Hinni, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 5779 E Mayo Blvd, Phoenix, AZ 85054 Phone: 480-301-8000 | |
Randy Oppenheimer, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 2601 E Roosevelt St, Department Of Surgery, Phoenix, AZ 85008 Phone: 602-344-5608 Fax: 602-344-1299 | |
Austin N Dehart, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 1920 E Cambridge Ave Ste 201, Phoenix, AZ 85006 Phone: 602-933-3277 Fax: 602-933-4326 | |
Griffin Santarelli, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 2910 N 3rd Ave # 330, Phoenix, AZ 85013 Phone: 602-406-8811 Fax: 602-406-8810 |